clindamycin has been researched along with Disease Models, Animal in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (40.00) | 18.7374 |
1990's | 14 (14.00) | 18.2507 |
2000's | 21 (21.00) | 29.6817 |
2010's | 20 (20.00) | 24.3611 |
2020's | 5 (5.00) | 2.80 |
Authors | Studies |
---|---|
Adams, DA; Donskey, CJ; Riggs, MM | 1 |
Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
Crandon, JL; Kuti, JL; Nicolau, DP | 1 |
Kirst, ME; Li, E; Liu, L; Wang, GP; Zhao, L | 1 |
Cornelissen, JJBWJ; de Boer, P; Jurburg, SD; Rebel, JMJ; Smits, MA | 1 |
Augusto, PSA; Braga, AV; Coelho, MM; Costa, FC; Costa, SOAM; Dutra, MMGB; Goulart, FA; Machado, RR; Melo, ISF; Morais, MI; Rodrigues, FF | 1 |
Mokale, SN; Patel, AM; Periasamy, H | 1 |
Barr, JR; Boyer, AE; Chabot, DJ; Cote, CK; Fetterer, DP; Friedlander, AM; Ingavale, S; Klimko, CP; Miller, JA; Schellhase, CW; Somerville, BC; Tobery, SA; Twenhafel, NA; Vietri, NJ; Woolfitt, AR; Wright, ME | 1 |
Kumamoto, CA; Lee, K; Markey, L; Pugliese, A; Roy, F; Tian, T | 1 |
Cadnum, J; Cresci, GAM; Donskey, C; Glueck, B; Obrenovich, M; Roychowdhury, S | 1 |
Bar-David, E; Ben-Shmuel, A; Brosh, T; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Aabed, K; Al-Marshoud, M; Al-Mutiri, M; Al-Qahtani, A; Ansary, A; Moubayed, N; Shafi Bhat, R | 1 |
Alvarez-Rocha, L; Arias, J; Azanza, JR; Barberán, J; Candel, F; de Alarcón, CA; Fortún, J; García, JE; Gómez, J; Grau, S; Llinares, P; Marco, F; Maseda, E; Mensa, J; Montejo, M; Moreno, A; Parra, J; Pasquau, J; Picazo, J; Salavert, M; Soriano, A; Soy, D | 1 |
Cai, WH; Feng, XM; Wang, JC; Yang, JD; Zhang, L; Zhang, N | 1 |
Andes, DR; Craig, WA; Jorgensen, JH; Lepak, AJ; Lewis, JS; Sabol-Dzintars, KE; Thompson, GR | 1 |
Lechner, AJ; Lechner, MG; Matuschak, GM; Vance, CO; Wilson, CN | 1 |
Berman, J; Fracisco, S; Gettayacamin, M; Li, Q; Melendez, V; Ohrt, C; Saunders, D; Teja-isavadharm, P; Xie, L | 1 |
Sriskandan, S; Turner, CE | 1 |
Böttger, EC; Bruhn, DF; Lee, RE; Lenaerts, AJ; Liu, J; Meibohm, B; Scherbakov, D; Scherman, MS | 1 |
Buechner, H; Henrich, D; Kontradowitz, K; Marzi, I; Meier, S; Nau, C; Schaible, A; Seebach, C; Trumm, A | 1 |
Cartman, ST; Cockayne, A; Collery, MM; Kelly, ML; Minton, NP; Ng, YK | 1 |
Andreoni, F; Keller, N; Marques Maggio, E; Neff, A; Poyart, C; Schilcher, K; Schuepbach, RA; Tarnutzer, A; Zinkernagel, AS; Zürcher, C | 1 |
Arodi, WO; Maloba, F; Nyachieo, A; Oduor, JM; Onkoba, N | 1 |
Boyd, KL; English, BK; Karlström, A; McCullers, JA | 1 |
Donskey, CJ; Jump, RL; Kypriotakis, G; Li, Y; Pultz, MJ | 1 |
Eržen, D; Milutinović, A; Nemec, A; Nemec-Svete, A; Pavlica, Z; Petelin, M | 1 |
Cheng, HW; Chia, JS; Hsu, RB; Jung, CJ; Lin, CS; Shun, CT; Yeh, CY | 1 |
Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
Azeh, I; Eiffert, H; Gerber, J; Koenig, B; Nau, R; Wellhausen, M; Wellmer, A | 1 |
Weiss, LM | 1 |
Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W | 1 |
Gerding, DN; Johnson, S; Merrigan, MM; Sambol, SP; Tang, JK | 2 |
Bobić, B; Djurković-Djaković, O; Grujić, J; Milenković, V; Nikolić, A | 1 |
Amâncio, RT; Bozza, FA; Bozza, PT; Castro-Faria-Neto, HC; David, CM; Gomes, RN; Vianna, RC | 1 |
Chuah, SK; Gollapudi, S; Thadepalli, H | 1 |
Baghdayan, AS; Donskey, CJ; Pultz, NJ; Shankar, N | 1 |
Smith, LD; Wilkins, TD | 1 |
Baines, SD; Freeman, J; Jabes, D; Wilcox, MH | 1 |
Bolduc, DL; Brook, I; Camp-Hyde, TD; Elliott, TB; Foriska, MA; Germana, A; Giraldo, DE; Jackson, WE; Ledney, GD; Shoemaker, MO; Thakar, JH | 1 |
Carman, RJ; Genheimer, CW; Gerding, DN; Geric, B; Johnson, S; Lyerly, DM; Rupnik, M; Sambol, SP | 1 |
Cheknis, A; Gerding, DN; Johnson, S; Nagaro, K; Razaq, N; Sambol, S; Zukowski, W | 1 |
Andes, DR; Craig, WA; LaPlante, KL; Leonard, SN; Rybak, MJ | 1 |
Justesen, T; Lykkegaard Nielsen, MC; Moesgaard, F | 1 |
Camas, JM; Geelhoed, GW; Miller, HG; Simon, GL | 1 |
Fabian, TC; Patterson, R | 1 |
Ebright, JR; Fekety, R; Silva, J; Wilson, KH | 1 |
Bartlett, JG | 2 |
Haglind, E; Haglund, U; Lundgren, O; Scherstén, T | 1 |
Bartlett, JG; Taylor, NS | 1 |
Clark, DG; Schweizer, RT | 1 |
Beale, AS; Bryant, JE; Gisby, J; Toseland, CD | 1 |
Hughes, WT; Killmar, JT; Oz, HS | 1 |
Oz, HS; Retsema, J; Tanowitz, HB; Wasserman, S; Weiss, LM; Wittner, M | 1 |
Anderson, LH; Mehm, WJ; Muhvich, KH | 1 |
Karlsson, E; Nilsson, B; Renneberg, J; Walder, M | 1 |
Kim, HK; McGregor, CG; Miller, VM; Odell, J; Park, YS; Steckelberg, JM; Tazelaar, HD | 1 |
Araujo, FG; Remington, JS; Suzuki, Y | 1 |
Heard, GS; Little, MD; Oloff, LM; Prins, DD; Wolfe, DA | 1 |
Bayer, A; Bolger, AF; Dajani, AS; Ferrieri, P; Gage, TW; Gewitz, MH; Hutto, C; Levison, ME; Newburger, JW; Nouri, S; Pallasch, TJ; Peter, G; Shulman, ST; Taubert, KA; Wilson, W; Zuccaro, G | 1 |
Boehnke, M; Garweg, JG; Kuenzli, H | 1 |
Agnello, D; Ghezzi, P; Meazza, C; Senaldi, G; Shaklee, CL; Villa, P | 1 |
Light, RW; Mulligan, ME; Nguyen, T; Sasse, SA; Teixeira, LR; Villarino, MA | 1 |
McVay, CS; Rolfe, RD | 1 |
Ano, H; Inokuma, H; Makimura, S; Wijaya, A; Wulansari, R | 1 |
Hiramatsu, K; Hirata, N; Ichimiya, T; Kishi, K; Nasu, M; Yamasaki, T | 1 |
Brown, IW; Hill, GB; Holland, JA; Osterhout, S; Saltzman, HA; Wolfe, WG | 1 |
Hamilton-Miller, JM | 1 |
Bartlett, JG; Gorbach, SL; Louie, TJ; Onderdonk, AB | 1 |
Bartlett, JG; Gorbach, SL; Kasper, DL; Louie, T; Onderdonk, AB | 1 |
Crow, J; Larson, HE; Price, AB | 1 |
Bartlett, JG; Chang, TW; Gorbach, SL; Gurwith, M; Onderdonk, AB | 1 |
Bartlett, JG; Chang, TW; Gorbach, SL; Onderdonk, AB | 1 |
Browne, RA; Ebright, JR; Fekety, R; Rifkin, GD; Silva, J | 1 |
Condon, CW; Humphrey, CD; Lushbaugh, WB; Pittman, FE; Pittman, JC | 1 |
Nitzan, D; Salyers, AA; Walker, CB; Wilkins, TD | 1 |
Nitzan, D; Walker, CB; Wilkins, TD | 1 |
Bartlett, JG; Cisneros, RL; Onderdonk, AB | 1 |
Abrams, GD; Boyd, DI; Browne, RA; Fekety, R; Silva, J; Work, CO | 1 |
Gerding, DN; Hall, WH; Kromhout, JP; Sullivan, JJ | 1 |
Johnson, ML; Sande, MA | 1 |
Amstutz, HC; Johnson, BL; Schurman, DJ | 1 |
Barza, M; Brown, RB; Brusch, JL; Hashimoto, Y; Weinstein, L | 1 |
Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
Bartlett, JG; Gorbach, SL; Louie, TJ; Onderdonk, AB; Weinstein, WM | 1 |
Bartlett, MS; Berman, JD; Dean, RA; Ellis, WY; Milhous, WK; Queener, SF; Smith, JW | 1 |
Bartlett, MS; Durkin, MM; Queener, SF; Shaw, MA; Smith, JW | 1 |
Daise, RL; Haberberger, RL; Ishak, EA; Mikhail, IA; Yonushonis, WP | 1 |
Eliopoulos, GM; Hindes, RG; Moellering, RC; Willey, SH | 1 |
Chang, TW; Dong, MY; Gorbach, SL | 1 |
Traub, WH | 1 |
Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
Bouffard, JA; Nolan, KD; Petry, NA; Pierson, CL; Schaberg, DR; Spaulding, SA; Stanley, JC; Wakefield, TW; Whitehouse, WM | 1 |
Barclay, FE; Borriello, SP; Ketley, JM; Mitchell, TJ; Price, AB; Stephen, J; Welch, AR | 1 |
Braden, TD; Caywood, DD; Gabel, CL; Johnson, CA; Lott, GA | 1 |
Larsen, PN; Lykkegaard Nielsen, MC; Moesgaard, F; Tvede, M | 1 |
Brown, GL; Cheadle, WG; Lamont, PM; Polk, HC; Trachtenberg, LS | 1 |
Ford, CW; Kinney, ML; Yancey, RJ | 1 |
Nozik, RA; O'Connor, GR; Tabbara, KF | 1 |
7 review(s) available for clindamycin and Disease Models, Animal
Article | Year |
---|---|
[Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Daptomycin; Disease Models, Animal; Fluoroquinolones; Fosfomycin; Guidelines as Topic; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2013 |
Babesiosis in humans: a treatment review.
Topics: Animals; Anti-Bacterial Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Humans; Naphthoquinones; Randomized Controlled Trials as Topic | 2002 |
Virulence factors of anaerobic bacteria.
Topics: Abdomen; Abscess; Anaerobiosis; Animals; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Guinea Pigs; Humans; Polysaccharides, Bacterial; Rats; Rats, Inbred Strains; Virulence | 1982 |
Antimicrobial agents acting against anaerobes.
Topics: Aminoglycosides; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Clindamycin; Colistin; Disease Models, Animal; Erythromycin; Fusidic Acid; Humans; Lactams; Lincomycin; Microbial Sensitivity Tests; Nitrofurans; Nitroimidazoles; Polymyxins; Rifamycins; Sulfamethoxazole; Tetracyclines; Trimethoprim; Vancomycin | 1975 |
A review. Lessons from an animal model of intra-abdominal sepsis.
Topics: Abdomen; Abscess; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Barium Sulfate; Cecum; Clindamycin; Disease Models, Animal; Enterobacteriaceae; Escherichia coli; Eubacterium; Fusobacterium; Gentamicins; Intestinal Perforation; Male; Peptococcus; Peritonitis; Rats; Sepsis | 1978 |
Antibiotic-associated colitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Culture Techniques; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1979 |
Re-examination of Rattus norvegicus as an animal model for Aeromonas-associated enteritis in man.
Topics: Aeromonas; Animals; Bacterial Infections; Clindamycin; Disease Models, Animal; Enteritis; Female; Humans; Male; Rats; Rats, Inbred Strains | 1991 |
93 other study(ies) available for clindamycin and Disease Models, Animal
Article | Year |
---|---|
Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
Topics: Anaerobiosis; Animals; Anti-Infective Agents; Bacterial Toxins; Cecum; Clostridioides difficile; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fluoroquinolones; Humans; Mice; Microbial Sensitivity Tests | 2007 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections; Vancomycin | 2010 |
Microbiome Resilience despite a Profound Loss of Minority Microbiota following Clindamycin Challenge in Humanized Gnotobiotic Mice.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Clindamycin; Disease Models, Animal; Dysbiosis; Feces; Gastrointestinal Diseases; Gastrointestinal Microbiome; Germ-Free Life; Humans; Male; Mice; RNA, Ribosomal, 16S | 2022 |
Successional Dynamics in the Gut Microbiome Determine the Success of
Topics: Animals; Anti-Bacterial Agents; Bacterial Shedding; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Feces; Gastrointestinal Microbiome; Microbial Interactions; Swine | 2019 |
Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Chemokine CXCL1; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Inflammation; Male; Mice; Pain; Piperidines; Pyrazoles; Tumor Necrosis Factor-alpha | 2020 |
Immunomodulatory dose of clindamycin in combination with ceftriaxone improves survival and prevents organ damage in murine polymicrobial sepsis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Bacterial Load; Ceftriaxone; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Female; Inflammation Mediators; Interleukin-6; Mice; Oxidative Stress; Peroxidase; Sepsis; Tumor Necrosis Factor-alpha | 2020 |
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacterial Toxins; Biomarkers; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Macaca mulatta; Prognosis; Respiratory Tract Infections; Treatment Outcome | 2021 |
Decreased Ecological Resistance of the Gut Microbiota in Response to Clindamycin Challenge in Mice Colonized with the Fungus Candida albicans.
Topics: Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cecum; Clindamycin; Disease Models, Animal; Feces; Female; Gastrointestinal Microbiome; Genetic Variation; Mice; Mice, Inbred C57BL | 2021 |
Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Anti-Inflammatory Agents; Butyrates; Clindamycin; Clostridioides difficile; Clostridium Infections; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Faecalibacterium prausnitzii; Feces; Female; Gastrointestinal Microbiome; Immunity, Innate; Prebiotics; Probiotics; Rats, Sprague-Dawley; Receptors, Immunologic; Solanum tuberosum; Starch; Tight Junction Proteins | 2018 |
Treating Anthrax-Induced Meningitis in Rabbits.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Antitoxins; Bacillus anthracis; Central Nervous System; Ciprofloxacin; Clindamycin; Dexamethasone; Disease Models, Animal; Drug Combinations; Imipenem; Levofloxacin; Linezolid; Meningitis, Bacterial; Meropenem; Rabbits; Treatment Failure | 2018 |
Ameliorative effect of probiotics (Lactobacillus paracaseii and Protexin®) and prebiotics (propolis and bee pollen) on clindamycin and propionic acid-induced oxidative stress and altered gut microbiota in a rodent model of autism.
Topics: Animals; Autistic Disorder; Bacteria; Bees; Clindamycin; Colony Count, Microbial; Cricetinae; Disease Models, Animal; Gastrointestinal Microbiome; Male; Oxidative Stress; Prebiotics; Probiotics; Propionates; Propolis; ROC Curve | 2019 |
Antibiotic penetration into rabbit nucleus pulposus with discitis.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Clindamycin; Discitis; Disease Models, Animal; Female; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.
Topics: Adult; Animals; Anti-Bacterial Agents; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Male; Mice; Mice, Inbred ICR; Middle Aged; Retrospective Studies; Streptococcal Infections; Streptococcus; Treatment Failure | 2014 |
Adenosine A1 receptor antagonist, L-97-1, improves survival and protects the kidney in a rat model of cecal ligation and puncture induced sepsis.
Topics: Adenosine A1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Cecum; Ceftriaxone; Clindamycin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Kidney; Ligation; Male; Peritonitis; Protective Agents; Purines; Rats, Sprague-Dawley; Sepsis | 2014 |
Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
Topics: Animals; Antibiotic Prophylaxis; Antimalarials; Clindamycin; Disease Models, Animal; Female; Macaca mulatta; Malaria; Mice; Mice, Inbred ICR; Parasitemia; Plasmodium cynomolgi; Plasmodium vivax; Recurrence | 2014 |
Panton-Valentine leucocidin expression by Staphylococcus aureus exposed to common antibiotics.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Toxins; Blotting, Western; Clindamycin; Disease Models, Animal; Exotoxins; Female; Humans; Leukocidins; Mice, Inbred BALB C; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2015 |
In vitro and in vivo Evaluation of Synergism between Anti-Tubercular Spectinamides and Non-Classical Tuberculosis Antibiotics.
Topics: Acute Disease; Animals; Antitubercular Agents; Clarithromycin; Clindamycin; Disease Models, Animal; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Half-Life; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2015 |
Alteration of Masquelet's induced membrane characteristics by different kinds of antibiotic enriched bone cement in a critical size defect model in the rat's femur.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Clindamycin; Disease Models, Animal; Femoral Fractures; Fracture Fixation, Internal; Gentamicins; Male; Materials Testing; Polymethyl Methacrylate; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 2016 |
Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetulus; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gene Expression; Genes, Synthetic; Genetic Engineering; Genome, Bacterial; Humans; Methyltransferases; Microbial Sensitivity Tests; Mutation; Survival Analysis; Virulence | 2016 |
Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Disease Models, Animal; Fasciitis, Necrotizing; Female; Humans; Mice, Inbred C57BL; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome; Virulence Factors | 2017 |
Efficacy of lytic Staphylococcus aureus bacteriophage against multidrug-resistant Staphylococcus aureus in mice.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biological Therapy; Clindamycin; Combined Modality Therapy; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Kenya; Male; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus Phages; Survival Analysis; Treatment Outcome; Viral Load; Wastewater | 2016 |
Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clindamycin; Disease Models, Animal; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Inflammation; Influenza A virus; Lung; Mice; Mice, Inbred BALB C; N-Acetylmuramoyl-L-alanine Amidase; Orthomyxoviridae Infections; Pneumonia, Pneumococcal; Protein Synthesis Inhibitors; Tumor Necrosis Factor-alpha | 2009 |
Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Colon; Disease Models, Animal; Enterocolitis, Pseudomembranous; Female; Humans; Mice; Minocycline; Tigecycline; Treatment Outcome | 2011 |
Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severe Porphyromonas gingivalis aspiration pneumonia in an experimental murine model.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Bacteroidaceae Infections; Bronchopneumonia; Chemotherapy, Adjuvant; Clindamycin; Dexamethasone; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lung; Male; Mice; Mice, Inbred BALB C; Nasal Sprays; Pneumonia, Aspiration; Porphyromonas gingivalis; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factor-alpha | 2012 |
Platelets enhance biofilm formation and resistance of endocarditis-inducing streptococci on the injured heart valve.
Topics: Animals; Anti-Bacterial Agents; Anticoagulants; Aspirin; Biofilms; Blood Platelets; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Endocarditis; Heart Valves; Host-Pathogen Interactions; Human Experimentation; Humans; Rats; Streptococcal Infections; Streptococcus gordonii; Streptococcus mutans | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
Protein synthesis inhibiting clindamycin improves outcome in a mouse model of Staphylococcus aureus sepsis compared with the cell wall active ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cell Wall; Cephalosporins; Clindamycin; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Protein Synthesis Inhibitors; Sepsis; Staphylococcal Infections; Treatment Outcome | 2002 |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2002 |
Colonization for the prevention of Clostridium difficile disease in hamsters.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Cricetinae; Cytotoxins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Mesocricetus; Probiotics; Time Factors | 2002 |
Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.
Topics: Acute Disease; Animals; Atovaquone; Brain; Clindamycin; Cysts; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Naphthoquinones; Toxoplasma; Toxoplasmosis, Animal | 2002 |
Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cecum; Ciprofloxacin; Clindamycin; Colony-Forming Units Assay; Cytokines; Disease Models, Animal; Endotoxins; Enzyme-Linked Immunosorbent Assay; Female; Gram-Negative Bacteria; Imipenem; Inflammation; Interleukin-10; Interleukin-6; Leukocytes; Lipopolysaccharides; Male; Mice; Sepsis; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fluoroquinolones; Injections, Subcutaneous; Levofloxacin; Male; Metronidazole; Mice; Moxifloxacin; Ofloxacin; Quinolines | 2004 |
Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice.
Topics: Animals; Bacterial Proteins; Clindamycin; Disease Models, Animal; Enterococcus faecalis; Gram-Positive Bacterial Infections; Lymph Nodes; Membrane Proteins; Mice | 2005 |
Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Disease Models, Animal; Fusobacterium; Fusobacterium Infections; Lincomycin; Male; Mice; Penicillins; Tetracycline | 1974 |
Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cecum; Clindamycin; Clostridioides difficile; Cricetinae; Depsipeptides; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gastrointestinal Contents; Male; Random Allocation; Time Factors; Vancomycin | 2005 |
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
Topics: Administration, Oral; Animals; Anthrax; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Blood; Ciprofloxacin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Gamma Rays; Injections, Subcutaneous; Liver; Lung; Mice; Moxifloxacin; Quinolines; Radiation Injuries, Experimental; Survival Analysis | 2005 |
Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Ileum; Immune Sera; Intestines; Mesocricetus; Rabbits; Trypsin | 2006 |
Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
Topics: Animals; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Male; Mesocricetus | 2007 |
Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vi
Topics: Acetamides; Animals; Anti-Bacterial Agents; Clindamycin; Colony Count, Microbial; Community-Acquired Infections; Culture Media; Daptomycin; Disease Models, Animal; Doxycycline; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thigh; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2008 |
Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Escherichia coli Infections; Gentamicins; Guinea Pigs; Premedication; Surgical Wound Infection | 1983 |
Penetration of clindamycin into experimental Staphylococcus aureus infections.
Topics: Animals; Capsules; Clindamycin; Disease Models, Animal; Peritoneal Cavity; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1984 |
Steroid therapy in septic shock. Survival studies in a laboratory model.
Topics: Animals; Cecum; Clindamycin; Disease Models, Animal; Female; Gentamicins; Glucocorticoids; Male; Methylprednisolone Hemisuccinate; Rats; Rats, Inbred Strains; Shock, Septic; Time Factors | 1982 |
Evaluation of eight cephalosporins in hamster colitis model.
Topics: Animals; Cecal Diseases; Cecum; Cephalosporins; Clindamycin; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Hemorrhage; Inflammation; Male; Mesocricetus | 1981 |
Graded intestinal vascular obstruction. II. Effects of antibiotic pretreatment in the rat.
Topics: Animals; Bacterial Infections; Bacterial Toxins; Clindamycin; Constriction; Disease Models, Animal; Female; Hematocrit; Intestines; Ischemia; Male; Rats; Shock | 1981 |
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
Topics: Absorption; Animals; Anion Exchange Resins; Anti-Bacterial Agents; Binding, Competitive; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Cricetinae; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Feces; Ion Exchange Resins; Male; Vancomycin | 1980 |
Use of antibiotics for prevention of Bacteroides fragilis wound sepsis in rats.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Carbenicillin; Chloramphenicol; Clindamycin; Disease Models, Animal; Injections, Intramuscular; Injections, Subcutaneous; Rats; Surgical Wound Infection | 1980 |
Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Floxacillin; Male; Osteomyelitis; Rats; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1994 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
Topics: Animals; Antimalarials; Azithromycin; Babesiosis; Ciprofloxacin; Clindamycin; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Mesocricetus; Organometallic Compounds; Quinine; Spiro Compounds; Survival Analysis | 1993 |
Evaluation of antimicrobials combined with hyperbaric oxygen in a mouse model of clostridial myonecrosis.
Topics: Animals; Clindamycin; Combined Modality Therapy; Disease Models, Animal; Female; Gas Gangrene; Hyperbaric Oxygenation; Imipenem; Injections, Intraperitoneal; Metronidazole; Mice; Mice, Inbred Strains; Necrosis; Penicillins; Survival Rate; Time Factors | 1994 |
Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model.
Topics: Animals; Clindamycin; Cloxacillin; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Netilmicin; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1993 |
An animal model of pulmonary infection after single lung transplantation.
Topics: Analysis of Variance; Animals; Cefazolin; Clindamycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Male; Neutrophils; Pneumonia, Bacterial; Postoperative Complications; Pulmonary Alveoli; Transplantation, Homologous | 1996 |
Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Brain; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Encephalitis; Female; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Rifabutin; Sulfadiazine; Toxoplasmosis, Cerebral; Treatment Outcome | 1996 |
PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Disease Models, Animal; Drug Delivery Systems; Gentamicins; Methylmethacrylates; Osteomyelitis; Rabbits; Staphylococcal Infections; Treatment Outcome | 1997 |
Prevention of bacterial endocarditis: recommendations by the American Heart Association.
Topics: Algorithms; American Dental Association; American Heart Association; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Clindamycin; Clinical Protocols; Consensus Development Conferences as Topic; Dental Care; Dental Care for Chronically Ill; Disease Models, Animal; Disease Susceptibility; Endocarditis, Bacterial; Erythromycin; Follow-Up Studies; Humans; MEDLINE; Mitral Valve Prolapse; Outcome Assessment, Health Care; Penicillins; Retrospective Studies; Risk Factors; Societies, Medical; Treatment Failure; United States | 1997 |
Experimental ocular toxoplasmosis in naive and primed rabbits.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Cell Count; Chorioretinitis; Clindamycin; Disease Models, Animal; Disease Progression; Female; Follow-Up Studies; Male; Rabbits; Retinal Detachment; Toxoplasma; Toxoplasmosis, Ocular; Vitreous Body | 1998 |
Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cecum; Clindamycin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gentamicins; Granulocyte Colony-Stimulating Factor; Interleukin-10; Interleukin-6; Leukocyte Count; Mice; Neutrophils; Peritonitis; Sepsis; Survivors; Tumor Necrosis Factor-alpha | 1998 |
Antibiotic levels in empyemic pleural fluid.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ceftriaxone; Clindamycin; Disease Models, Animal; Empyema, Pleural; Gentamicins; Humans; Infusions, Intravenous; Metronidazole; Pasteurella Infections; Pasteurella multocida; Penicillins; Rabbits; Vancomycin | 2000 |
In vitro and in vivo activities of nitazoxanide against Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Metronidazole; Microbial Sensitivity Tests; Nitro Compounds; Thiazoles; Vancomycin | 2000 |
Therapeutic effect of clindamycin and tetracycline on Babesia rodhaini infection in mouse model.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Babesia; Babesiosis; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Male; Mice; Recurrence; Rodent Diseases; Tetracycline | 2000 |
Infection of hamsters with epidemiologically important strains of Clostridium difficile.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Clindamycin; Clostridioides difficile; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Disease Outbreaks; Enterocolitis, Pseudomembranous; Erythromycin; Mesocricetus; Microbial Sensitivity Tests; Polymerase Chain Reaction; Restriction Mapping; Virulence | 2001 |
Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cytokines; Disease Models, Animal; Escherichia coli; Lipopolysaccharides; Male; Mice; Mice, Inbred C3H; Shock, Septic | 2001 |
Experimental and clinical experience with hyperbaric oxygen in the treatment of clostridial myonecrosis.
Topics: Adult; Amputation, Surgical; Antitoxins; Bacteroides Infections; Cephalothin; Clindamycin; Clostridium perfringens; Debridement; Disease Models, Animal; Evaluation Studies as Topic; Female; Gas Gangrene; Gentamicins; Humans; Hyperbaric Oxygenation; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Resuscitation; Surgical Wound Infection; Wound Infection | 1975 |
Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.
Topics: Abdomen; Abscess; Animals; Bacteroides fragilis; Cephalosporins; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli; Fusobacterium; Gentamicins; Male; Microbial Sensitivity Tests; Rats; Streptococcus | 1977 |
Morphology of experimental antibiotic-associated enterocolitis in the hamster: a model for human pseudomembranous colitis and antibiotic-associated diarrhoea.
Topics: Animals; Cecum; Clindamycin; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Intestinal Mucosa; Mesocricetus; Microscopy, Electron; Vancomycin | 1979 |
Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antitoxins; Bacterial Toxins; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Diarrhea; Disease Models, Animal; Enterocolitis, Pseudomembranous; Humans; Mesocricetus | 1978 |
Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients.
Topics: Animals; Antitoxins; Bacterial Toxins; Clindamycin; Clostridium; Cricetinae; Cytotoxins; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans | 1978 |
Clindamycin-induced colitis.
Topics: Animals; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Clostridium Infections; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Mesocricetus; Metronidazole; Vancomycin | 1979 |
Light and electron microscopic studies of antibiotic associated colitis in the hamster.
Topics: Animals; Cecum; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Intestinal Mucosa; Lincomycin; Mesocricetus; Microscopy, Electron; Microscopy, Electron, Scanning | 1979 |
Experimental infections with anaerobic bacteria in mice.
Topics: Anaerobiosis; Animals; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Disease Models, Animal; Fusobacterium Infections; Fusobacterium necrophorum; Mice | 1977 |
Chemotherapy of an experimental Bacteroides fragilis infection in mice.
Topics: Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Cephalothin; Chloramphenicol; Clindamycin; Disease Models, Animal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillin G; Tetracycline | 1977 |
Clindamycin-associated colitis in hamsters: protection with vancomycin.
Topics: Animals; Clindamycin; Colon; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Gentamicins; Lincomycin; Male; Vancomycin | 1977 |
The protective effect of vancomycin on clindamycin-induced colitis in hamsters.
Topics: Administration, Oral; Animals; Clindamycin; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Injections, Subcutaneous; Intestines; Male; Vancomycin | 1977 |
Antibiotic penetrance of ascitic fluid in dogs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Ascites; Ascitic Fluid; Cephalosporins; Clindamycin; Disease Models, Animal; Dogs; Half-Life; Metronidazole; Time Factors | 1976 |
Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cephalothin; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Penicillins; Rabbits; Rifampin; Staphylococcal Infections; Time Factors; Vancomycin | 1975 |
Knee joint infections with Staphylococcus aureus and Micrococcus species.
Topics: Animals; Arthritis, Infectious; Arthroplasty; Bacterial Infections; Cephacetrile; Clindamycin; Cortisone; Disease Models, Animal; Hemarthrosis; Knee Joint; Methicillin; Microbial Sensitivity Tests; Micrococcus; Prednisolone; Rabbits; Sepsis; Stainless Steel; Staphylococcal Infections; Staphylococcus; Surgical Wound Infection | 1975 |
Pharmacokinetics of lincomycin and clindamycin phosphate in a canine model.
Topics: Animals; Bile; Biliary Tract Diseases; Clindamycin; Disease Models, Animal; Dogs; Hepatic Veins; Kidney; Lincomycin; Liver; Portal Vein | 1975 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
Antimicrobial therapy of experimental intraabdominal sepsis.
Topics: Abscess; Animals; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Gentamicins; Peritonitis; Rats | 1975 |
Efficacy of intermittent dosage of 8-aminoquinolines for therapy or prophylaxis of Pneumocystis pneumonia in rats.
Topics: Aminoquinolines; Animals; Clindamycin; Disease Models, Animal; Drug Administration Schedule; Female; Pneumonia, Pneumocystis; Primaquine; Rats; Rats, Inbred Strains; Specific Pathogen-Free Organisms; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Inoculated mouse model of Pneumocystis carinii infection.
Topics: Aminoquinolines; Animals; Antimalarials; Clindamycin; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Immunosuppression Therapy; Mice; Mice, Inbred BALB C; Pneumocystis Infections; Primaquine; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Effects of clindamycin and gentamicin and other antimicrobial combinations against enterococci in an experimental model of intra-abdominal abscess.
Topics: Abdominal Muscles; Abscess; Ampicillin; Animals; Clindamycin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Enterococcus faecalis; Gentamicins; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Peritoneal Diseases; Rats; Rats, Inbred Strains; Streptococcal Infections | 1989 |
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Cricetinae; Daptomycin; Disease Models, Animal; Enterocolitis, Pseudomembranous; Male; Mesocricetus; Peptides; Vancomycin | 1987 |
Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
Topics: Animals; Ciprofloxacin; Clindamycin; Clostridium perfringens; Disease Models, Animal; Gas Gangrene; Imipenem; Mice; Microbial Sensitivity Tests; Penicillin G; Rifampin | 1988 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
Treatment of established prosthetic vascular graft infection with antibiotics preferentially concentrated in leukocytes.
Topics: Animals; Blood Vessel Prosthesis; Cefazolin; Clindamycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Female; Leukocytes; Rifampin; Staphylococcal Infections; Surgical Wound Infection | 1987 |
Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis.
Topics: Animals; Bacterial Proteins; Bacterial Toxins; Cecum; Clindamycin; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Intestinal Mucosa; Intestine, Small; Mesocricetus; Virulence | 1987 |
Posologic evaluation of clindamycin, using a canine model of posttraumatic osteomyelitis.
Topics: Animals; Clindamycin; Disease Models, Animal; Dog Diseases; Dogs; Female; Leg Injuries; Male; Osteomyelitis; Staphylococcal Infections | 1987 |
Reduction of experimental wound infection rate by administration of clindamycin in addition to netilmicin.
Topics: Animals; Bacteria, Aerobic; Bacteria, Anaerobic; Clindamycin; Disease Models, Animal; Double-Blind Method; Drug Therapy, Combination; Netilmicin; Premedication; Random Allocation; Surgical Wound Infection | 1986 |
Effects of muramyl dipeptide and clindamycin in a murine abdominal abscess model.
Topics: Abdomen; Abscess; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Clindamycin; Disease Models, Animal; Drug Therapy, Combination; Humans; Male; Mice; Peritonitis; Rats | 1986 |
Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Cloxacillin; Disease Models, Animal; Female; Injections; Injections, Subcutaneous; Kinetics; Lactation; Lincomycin; Lincosamides; Macrolides; Mammary Glands, Animal; Mastitis; Mastitis, Bovine; Mice; Microbial Sensitivity Tests; Novobiocin; Pregnancy; Rifamycins; Staphylococcal Infections | 1985 |
Clindamycin effects on experimental ocular toxoplasmosis in the rabbit.
Topics: Animals; Chorioretinitis; Clindamycin; Disease Models, Animal; Eye; Female; Fluorescent Antibody Technique; Injections; Male; Rabbits; Staining and Labeling; Toxoplasma; Toxoplasmosis, Ocular | 1974 |